Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-28,871
Closed -$2.96M 1655
2026
Q1
$2.96M Buy
+28,871
New +$3.26M 0.06% 535
2025
Q2
Sell
-1,850
Closed -$245K 1592
2025
Q1
$245K Buy
+1,850
New +$235K 0.02% 973
2024
Q4
Sell
-48,106
Closed -$5.48M 1127
2024
Q3
$5.48M Buy
+48,106
New +$5.28M 0.34% 42
2024
Q2
Sell
-19,633
Closed -$2.23M 1329
2024
Q1
$2.23M Buy
+19,633
New +$2.25M 0.17% 149
2023
Q4
Sell
-26,403
Closed -$2.56M 1177
2023
Q3
$2.56M Buy
+26,403
New +$2.77M 0.25% 97
2022
Q4
Sell
-15,860
Closed -$1.53M 949
2022
Q3
$1.53M Buy
15,860
+8,045
+103% +$857K 0.15% 206
2022
Q2
$849K Buy
+7,815
New +$888K 0.11% 271
2021
Q4
Sell
-9,908
Closed -$1.17M 547
2021
Q3
$1.17M Buy
+9,908
New +$1.22M 0.21% 149
2021
Q2
Sell
-4,635
Closed -$555K 593
2021
Q1
$555K Buy
4,635
+955
+26% +$113K 0.15% 228
2020
Q4
$399K Buy
+3,680
New +$400K 0.17% 218

Other funds holding ABT

Y-Intercept (HK)'s ABT Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Abbott (ABT) in Q2 2026, closing a stake of 28,871 shares — an estimated $2.96M sold.

Y-Intercept (HK) first reported a position in ABT in Q4 2020 and held it in 10 quarters. The position peaked at $5.48M in Q3 2024. 820 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 28,871 Abbott shares in Q2 2026, an estimated $2.96M.
  • Y-Intercept (HK) first reported a position in Abbott in Q4 2020 and held it in 10 quarters.
  • Y-Intercept (HK)'s Abbott position peaked at $5.48M in Q3 2024.
  • 820 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.